Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLNB in cN0 High-Risk cSCC of the Head and Neck
NCT06990737Phase 2Withdrawn
- Sponsor
- University of California, Davis
- Start
- Jun 2025
- Primary completion
- Jun 2026
01
Overview
Phase 2, open-label, single-arm trial in cutaneous squamous cell carcinoma (cSCC), sponsored by University of California, Davis. Primary endpoint: Disease-Free Survival at 2 years. Planned start Jun 2025; status: withdrawn.
02
Conditions
cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on NCT06990737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06990737.